Arcellx (ACLX) Current Deferred Revenue (2021 - 2025)

Arcellx (ACLX) recorded quarterly Current Deferred Revenue of $56.0 million in Q4 2025, down 6.33% quarter-over-quarter from $59.8 million in Q3 2025, and down 58.56% on a YoY basis from $135.1 million in Q4 2024.

Arcellx (ACLX) Current Deferred Revenue (2021 - 2025) Analysis & Trends

Arcellx's Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $56.0 million for Q4 2025.

  • In Q4 2025, Current Deferred Revenue fell 58.56% year-over-year to $56.0 million; the TTM figure through Dec 2025 stood at $56.0 million (down 58.56% YoY), while the FY2025 annual figure was $56.0 million, down 58.56% from the prior year.
  • Current Deferred Revenue was $56.0 million for Q4 2025 at Arcellx, down from $59.8 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $221.2 million in Q4 2023 to a low of $183000.0 in Q4 2021.
  • Historically, Current Deferred Revenue has averaged $76.9 million across 4 years, with a median of $59.8 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue sank 84.05% in 2024, then soared 296.27% in 2025.
  • A 4-year view of Current Deferred Revenue shows it stood at $183000.0 in 2021, then soared by 120777.6% to $221.2 million in 2023, then tumbled by 38.95% to $135.1 million in 2024, then plunged by 58.56% to $56.0 million in 2025.
  • The last three Current Deferred Revenue figures came in at $56.0 million (Q4 2025), $59.8 million (Q3 2025), and $59.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Arcellx 6.48 Bn 6.48 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 55.97 Mn
Sep 30, 2025 59.75 Mn
Jun 30, 2025 59.32 Mn
Mar 31, 2025 57.37 Mn
Dec 31, 2024 135.05 Mn
Sep 30, 2024 69.87 Mn
Jun 30, 2024 14.97 Mn
Mar 31, 2024 31.19 Mn
Dec 31, 2023 221.21 Mn
Sep 30, 2023 94.18 Mn
Jun 30, 2023 93.88 Mn
Mar 31, 2023 107.29 Mn
Dec 31, 2021 183,000.00